Nassib Chamoun is Founder and Managing Director of G6 Capital Management, a quantitative money management firm established in 2012 to invest private capital using mathematical and statistical techniques that leverage over 30 years’ experience in modeling biological and healthcare systems.
Chamoun was Founder, President and CEO of Aspect Medical Systems, which he helped grow into a $100M global, public company. Aspect’s premier product the Bispectral Index™ (BIS™) technology is the first clinically validated direct measure of the effects of anesthetics on the brain. BIS™ technology is available in a majority of hospitals in the US, Europe and Japan, has been used clinically in approximately 50 million patients and has been the subject of more than 3,500 published articles and abstracts. BIS™ technology has been proven to reduce the risk of awareness with recall during surgery, facilitate faster wake-ups with less recovery time and reduce anesthetic use.
In 2009, Chamoun guided the acquisition of Aspect Medical Systems by Covidien, a leading $12 billion global healthcare products company. From 2009 to 2010 he assisted the CEO of Covidien in the capacity of Vice President of Technology, Research and Clinical Development.
Chamoun is a member of the Northeastern University Corporation.